Mylanta Max Strength Classic flavor antacid recalled for improper storage conditions
Mylanta Max Strength Classic flavor antacid (12 fl oz, SKU 999844) has been recalled due to improper storage temperature conditions. The product was distributed nationwide to Family Dollar Stores from April 30 to June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for CGMP deviations involving improper storage temperature. No illnesses or injuries reported; the hazard relates to product quality and potential loss of efficacy rather than direct safety risk.
Plain-English summary
Mylanta Max Strength Classic flavor antacid in 12 fl oz bottles (SKU 999844) distributed by Family Dollar Stores, Llc. has been recalled. The product was distributed nationwide to select Family Dollar Stores between April 30, 2022 and June 10, 2022.
The FDA issued this Class II recall due to Current Good Manufacturing Practice (CGMP) deviations. The product was held outside appropriate storage temperature conditions.
Consumers who may have purchased this product from Family Dollar Stores during the distribution period (April 30 to June 10, 2022) may have the recalled product.
The recalled product
- Product
- MYLANTA MAX STRENGTH CLASSIC FLVR 12 FLOZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Antacid
- Hazard
- improper-storage
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 999844
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27